Another RCT found that ω-3 FAs capsules significantly reduced the Glasgow Prognostic Score (GPS), a prognostic cancer marker based on inflammation composed of CRP and albumin, in patients with local advanced rectal cancer receiving neoadjuvant radiotherapy [96]. This evidence concerns the gene ALB and cancer.